Articles related to INSURANCE

Discover how the 340B Drug Pricing Program influences prescription trends toward higher-cost biologics over biosimilars, and what this means for cost-effective healthcare.

New research underscores the dramatic increase in prior authorization for oral oncology drugs under Medicare Part D. Understand the implications for your practice as insurers tighten their grip on treatment decisions.

Explore the complexities and challenges that could arise for oncologists with the potential expansion of blood biopsy insurance coverage through the MCED Screening Coverage Act.

Explore the potential implications of the formation of Risant Health on community oncology, as discussed by industry experts in a recent episode of Cancer Care Business Breakthroughs. Learn about the potential challenges and opportunities this new entity could bring to the healthcare landscape.

Unpacking the landmark summit led by the American Pharmacists Association, it becomes clear that there is a pressing need and opportunity to expand healthcare coverage for pharmacists’ patient care services, promising substantial impacts on patient care and health systems.

Similarities in Quality and Cost of Care: Allopathic vs. Osteopathic Physicians As the medical field continues to evolve and diversify, it is imperative to understand the impact of physician education on patient outcomes and healthcare costs. This comprehensive observational study offers an insightful comparison between allopathic and osteopathic physicians in the context of hospitalized Medicare patients, revealing striking similarities in both the quality and cost of care provided.